391 related articles for article (PubMed ID: 31238416)
1. Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma.
Maheshwari D; Kanduri S; Kadar MA; Ramakrishnan R; Pillai MR
Indian J Ophthalmol; 2019 Jul; 67(7):1080-1084. PubMed ID: 31238416
[TBL] [Abstract][Full Text] [Related]
2. Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.
Koh V; Chen D; Aquino CM; Aduan J; Sng C; Chee LS; Chew P
Jpn J Ophthalmol; 2017 May; 61(3):245-252. PubMed ID: 28188405
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Sihota R; Angmo D; Chandra A; Gupta V; Sharma A; Pandey RM
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1153-9. PubMed ID: 25940554
[TBL] [Abstract][Full Text] [Related]
7. Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma.
Tanaka D; Nakanishi H; Hangai M; Akagi T; Morooka S; Ikeda HO; Yoshimura N
Jpn J Ophthalmol; 2016 Nov; 60(6):446-453. PubMed ID: 27517556
[TBL] [Abstract][Full Text] [Related]
8. Phacotrabeculectomy without mitomycin C in primary angle-closure and open-angle glaucoma.
Rao HL; Maheshwari R; Senthil S; Prasad KK; Garudadri CS
J Glaucoma; 2011 Jan; 20(1):57-62. PubMed ID: 20051881
[TBL] [Abstract][Full Text] [Related]
9. Deep sclerectomy augmented with combination of absorbable biosynthetic sodium hyaluronate scleral implant and mitomycin C or with mitomycin C versus trabeculectomy: long-term results.
Mesci C; Erbil HH; Karakurt Y; Akçakaya AA
Clin Exp Ophthalmol; 2012; 40(4):e197-207. PubMed ID: 21668789
[TBL] [Abstract][Full Text] [Related]
10. Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C.
Hoang TKH; Kim YK; Jeoung JW; Park KH
Eye (Lond); 2018 Aug; 32(8):1321-1328. PubMed ID: 29581522
[TBL] [Abstract][Full Text] [Related]
11. Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
Takihara Y; Inatani M; Ogata-Iwao M; Kawai M; Inoue T; Iwao K; Tanihara H
JAMA Ophthalmol; 2014 Jan; 132(1):69-76. PubMed ID: 24232829
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma.
Kobayashi H; Kobayashi K; Okinami S
Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):359-66. PubMed ID: 12698257
[TBL] [Abstract][Full Text] [Related]
13. Postoperative complications after glaucoma surgery for primary angle-closure glaucoma vs primary open-angle glaucoma.
Tan YL; Tsou PF; Tan GS; Perera SA; Ho CL; Wong TT; Aung T
Arch Ophthalmol; 2011 Aug; 129(8):987-92. PubMed ID: 21482857
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up.
Bindlish R; Condon GP; Schlosser JD; D'Antonio J; Lauer KB; Lehrer R
Ophthalmology; 2002 Jul; 109(7):1336-41; discussion 1341-2. PubMed ID: 12093659
[TBL] [Abstract][Full Text] [Related]
15. Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population.
Sihota R; Gupta V; Agarwal HC
Clin Exp Ophthalmol; 2004 Feb; 32(1):23-8. PubMed ID: 14746586
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
17. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.
Sen M; Midha N; Sidhu T; Angmo D; Sihota R; Dada T
Ophthalmol Glaucoma; 2018; 1(2):88-98. PubMed ID: 32677614
[TBL] [Abstract][Full Text] [Related]
18. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Kashiwagi K; Kogure S; Mabuchi F; Chiba T; Yamamoto T; Kuwayama Y; Araie M;
Acta Ophthalmol; 2016 Nov; 94(7):e561-e570. PubMed ID: 27156361
[TBL] [Abstract][Full Text] [Related]
19. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C-augmented Phacotrabeculectomy Versus Phacoemulsification in Primary Angle-closure Glaucoma: A Randomized Controlled Study.
El Sayed YM; Elhusseiny AM; Albalkini AS; El Sheikh RH; Osman MA
J Glaucoma; 2019 Oct; 28(10):911-915. PubMed ID: 31469675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
